Advanced search
Publication Cover
Journal of Market Access & Health Policy Volume 7, 2019 - Issue 1
Journal homepage
2,331
Views
12
CrossRef citations to date
0
Altmetric
Original Research Article

Economic burden for Alzheimer’s disease in China from 2010 to 2050: a modelling study

Emilie ClayHealth Economics and Outcomes Research Department, Creativ-Ceutical, Paris, FranceCorrespondence[email protected]
,
Junwen ZhouPublic Health Department – Research Unit EA 3279, Aix-Marseille University, Marseille, France
,
Zhan-Miao YiDepartment of Pharmacy, Peking University Third Hospital, Beijing, China;Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University Health Science Center, Beijing, China;Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China
,
Suodi ZhaiDepartment of Pharmacy, Peking University Third Hospital, Beijing, China
&
Mondher ToumiPublic Health Department – Research Unit EA 3279, Aix-Marseille University, Marseille, FranceORCID Iconhttps://orcid.org/0000-0001-7939-7204
ORCID Icon
Article: 1667195 | Received 06 Dec 2018, Accepted 09 Sep 2019, Published online: 26 Sep 2019

References

  • Fox NC, Rossor MN. Diagnosis of early Alzheimer’s disease. Rev Neurol (Paris). 1999;155(Suppl 4):S33–7.
  • Li XL, Hu N, Tan MS, et al. Behavioral and psychological symptoms in Alzheimer’s disease. Biomed Res Int. 2014;2014:927804.
  • Prince M, Albanese E, Guerchet M, et al. World Alzheimer Report 2014. Dementia and Risk Reduction - an analysis of protective and modifiable factors. London; 2014.
  • Wimo A, Winblad B, Grafstrom M. The social consequences for families with Alzheimer’s disease patients: potential impact of new drug treatment. Int J Geriatr Psychiatry. 1999;14:338–347.
  • Prince M, Wimo A, Guerchet M, et al. World Alzheimer Report 2015.The global economic impact of dementia. London; 2015.
  • Wimo A, Prince M. World Alzheimer Report 2010. The global economic impact of dementia. London; 2010.
  • Liu BY, Wang JL, Xiao YZ. [Prevalence of senile dementia in people aged >/=60 years in China: a Meta-analysis]. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37:1541–1545.
  • Chan KY, Wang W, Wu JJ, et al. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013;381:2016–2023.
  • Keogh-Brown MR, Jensen HT, Arrighi HM, et al. The impact of Alzheimer’s disease on the Chinese economy. EBioMedicine. 2016;4:184–190.
  • Chen R, Hu Z, Chen RL, et al. Determinants for undetected dementia and late-life depression. Br J Psychiatry. 2013;203:203–208.
  • Wang G, Cheng Q, Zhang S, et al. Economic impact of dementia in developing countries: an evaluation of Alzheimer-type dementia in Shanghai, China. J Alzheimers Dis. 2008;15:109–115.
  • USA Census Bureau. International Data Base. Available from https://www.census.gov/data-tools/demo/idb/region.php?N=%20Results%20&T=13&A=separate&RT=0&Y=2010,2020,2030,2040,2050&R=−1&C=CH. Assess on 2019 Sep 05.
  • Li A Dementia in China (2010-2050) Estimated Using the 2010 Census: suzhou University; 2015.
  • Ban CX, Xiao SF, Lin X, et al. Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai. Transl Neurodegener. 2016;5:8.
  • Hu S, Yu X, Chen S, et al. Memantine for treatment of moderate or severe Alzheimer’s disease patients in urban China: clinical and economic outcomes from a health economic model. Expert Rev Pharmacoecon Outcomes Res. 2015;15:565–578.
  • Yu X, Chen S, Chen X, et al. Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study. Transl Neurodegener. 2015;4:15.
  • Tang B, Harary E, Kurzman R, et al. Clinical characterization and the Caregiver Burden of Dementia in China. Value Health Reg Issues. 2013;2:118–126.
  • 2016 annual statistics report of China health and family planning commission. China Peking Union Medical University Press; [cited 2017 Oct 08]. Available from http://cnki.heinfo.gov.cn/csydkns/navi/YearBook.aspx?id=N2015110062&floor=1
  • Yang Y, He J, Kang Q, et al. Analysis of the medical service utilization and expenses of the hospitalized patients with Alzheimer’s Disease in Shanghai. ISPOR 22th Annual International Meeting; Boston; 2017.
  • Zhang ZX, Chen X, Liu XH, et al. [A caregiver survey in Beijing, Xi’an, Shanghai and Chengdu: health services status for the elderly with dementia]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004;26:116–121.
  • Alzheimer’s A. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement. 2016;12:459–509.
  • Hu S, Yu X, Chen S, et al. Pharmacoeconomic model for Memantine for treatment of Alzheimer’s disease patients in China. China J Pharm Econ. 2016;9:7–17. Article in Chinese.
  • Jia J, Wang F, Wei C, et al. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement. 2014;10:1–9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.